The Articles page brings together health economics editorial themes, in-depth analysis, and useful content for decision-makers.
SanticxisHealth Economics AdvisoryA page dedicated to the firm’s analysis, the founder’s publications, and key themes in health economics.
The Articles page brings together health economics editorial themes, in-depth analysis, and useful content for decision-makers.
Economic evaluation • 7 min read
From constrained budgets to growing accountability demands, economic evaluation is no longer optional: it structures decision-making.
Read the articleMarket access • 7 min read
Evidence quality, local context, and clarity of positioning often make the difference.
Read the articleTraining • 6 min read
A strong training program does more than transfer tools: it makes teams more autonomous and more strategic.
Read the articleHTA • 8 min read
A sound healthcare decision does not rely on a single metric: it combines value, affordability, and institutional context.
Read the articleReimbursement • 8 min read
Reimbursement does not depend on clinical innovation alone: value, affordability, and institutional relevance must also be demonstrated.
Read the articleBudget impact • 4 min
Budget impact analysis helps decision-makers understand whether an innovation is affordable under real adoption conditions.
Read the articleHTA • 6 min
A strong HTA dossier is not only complete. It helps reviewers quickly understand value, limitations, and adoption conditions.
Read the articleQALY & utilities • 4 min
QALYs and utilities integrate both length and quality of life into healthcare decisions, but their interpretation requires method and caution.
Read the articlePrioritization • 4 min
Healthcare prioritization requires making value criteria, constraints, and the consequences of collective choices explicit.
Read the articleEvidence • 4 min
Evidence has strategic value only when it is structured, interpreted, and translated into clear decision options.
Read the articlePharmacoeconomics • 6 min
Pharmacoeconomics connects clinical effectiveness, costs, reimbursement, and affordability to support decisions around medicines and therapeutic innovations.
Read the articleReal-world evidence • 6 min
Real-world evidence can strengthen economic evaluations when used with method, transparency, and caution.
Read the articleEquity • 6 min
Integrating equity into economic evaluation helps clarify who benefits, who remains at risk, and which trade-offs are acceptable.
Read the articleCost-effectiveness • 6 min
The cost-effectiveness threshold is useful, but it should not be interpreted as an automatic rule for reimbursement or adoption.
Read the articleModeling • 6 min
Markov models are central tools for representing patient progression over time, costs, events, and health outcomes.
Read the articleChronic diseases • 6 min
Chronic diseases require long-term choices around prevention, treatment, monitoring, complications, quality of life, and health system affordability.
Read the articleScoping • 6 min
A successful health economic evaluation starts with precise scoping: decision question, perspective, comparator, data, time horizon, and expected deliverables.
Read the articleA practical guide to getting started with cost-effectiveness analysis and decision modeling.
This book offers a progressive introduction to health economic evaluation methods, cost-effectiveness analysis, QALYs, utilities, and the core principles of decision modeling.
A resource designed to make health economic evaluation more accessible, more practical, and methodologically rigorous.